Expression of Master Regulators of Helper T-Cell Differentiation in Peripheral T-Cell Lymphoma, Not Otherwise Specified, by Immunohistochemical Analysis

Department of Molecular Hematology and Oncology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kawaramachi Hirokoji, Kamigyo-ku, 602-8566, Kyoto, Japan.
American Journal of Clinical Pathology (Impact Factor: 2.51). 02/2010; 133(2):281-90. DOI: 10.1309/AJCP0SBHYVLY5EML
Source: PubMed


The normal counterparts of peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) have not been accurately identified. We immunohistochemically analyzed 10 PTCL-NOS cases to examine the expression of the master regulators of T-cell differentiation and of surface antigens, including chemokine receptors. All cases were positive for the master regulator of helper T cells (Th-POK) and the marker of effector T cells (CD45RO). Three cases each were positive for T-Bet and GATA3, which are master regulators of helper T cells (T(H) ) type 1 (T(H)1) and 2 (T(H)2), respectively. Two cases were positive for the surface antigens of central memory (Tcm) (CCR7 and CD62L), and 1 case was positive for follicular helper T-cell (TFH) phenotype (BCL6, CXCL13, and PD-1). The remaining case was negative for all markers of effector T(H) subtypes. These results suggest the postulated normal counterparts of PTCL-NOS identified in 9 of the 10 cases consist of T(H)1, T(H)2, TCM, and TFH.

Download full-text


Available from: Junya Kuroda, Jan 07, 2016
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper presents an implementation of an adaptive digital filter. The hardware is outlined and the limitations of the design discussed. The effect of rounding on the filter characteristics is described. A method of improving filter performance, when using low adaptive gains, by means of the addition of a dither signal to the coefficient updates is described. Experimental results from the implementation are presented. These results concur with trends predicted by computer simulations, results of which are also included. Potential applications are suggested as are methods for improving the design.
    No preview · Conference Paper · Jun 1982
  • [Show abstract] [Hide abstract]
    ABSTRACT: With the wider usages of OPC and PSM technologies in current UDSM IC manufacturing, a new step of verifying the layout modifications is needed. Reasons to employ such a step are discussed in this paper. The architecture of a post-OPC silicon verification tool which has the full capability to accomplish such a verification task is presented in detail. Process modelling and some accelerating algorithms implemented in this tool are detailed as well. Real verification examples are also demonstrated.
    No preview · Conference Paper · Nov 2003
  • [Show abstract] [Hide abstract]
    ABSTRACT: The classification of malignant lymphomas remained controversial for over 30 years. The first scheme was proposed by Rappaport in the '60th and was based on incorrect histogenetic concepts. To overcome these limitations, several groups formulated new proposals in '70th. Among these two merited attention: the Lukes and Collins and the Kiel Classifications. They were based on the assumption that each lymphoma category might be related to a precise differentiation step of the lymphoid system, thus excluding any correlation with histiocytes, present on the Rappaport scheme. The Kiel Classification became very popular in Europe, while the one of Luke and Collins did not meet success in the United States (U.S.). In 1978, the National Cancer Institute proposed an international trial to compare the classifications used in Europe and U.S. The result was the genesis of the Working formulation, the tool for lymphoma classification in the U.S. up to the early '90th, but which was conversely rejected in Europe. In order to get over this lack of transatlantic communication, in 1994 the Revised European-American Lymphoma (REAL) Classification was proposed by the International Lymphoma Study Group. Its goal was to list "real" entities, each defined by the presence of homogeneous morphologic, phenotypic, cytogenetic, molecular, and clinical criteria, along with the possible recognition of its normal counterpart. The REAL Classification became the model for the WHO Classification of all haematopoietic tumours published in 2001. The present review aims to analyse future perspectives after the fourth edition of the WHO Classification released in 2008.
    No preview · Article · May 2011 · Seminars in Diagnostic Pathology
Show more